Table 3.
Comparison of hearing by age groups in MetS and non-MetS subjects.
| Age (Years) | Non-MetS | MetS | p-Value a | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Normal | Hearing Loss | Total | Normal | Hearing Loss | Total | ||||||
| 20–29 | 4645 | (99.06%) | 44 | (0.94%) | 4689 | 272 | (98.19%) | 5 | (1.81%) | 277 | 0.1943 |
| 30–39 | 20,996 | (97.78%) | 477 | (2.22%) | 21,473 | 2309 | (96.81%) | 76 | (3.19%) | 2385 | 0.0041 * |
| 40–49 | 32,068 | (92.98%) | 2422 | (7.02%) | 34,490 | 4465 | (91.48%) | 416 | (8.52%) | 4881 | 0.0002 * |
| 50–59 | 14,199 | (79.26%) | 3715 | (20.74%) | 17,914 | 2316 | (76.84%) | 698 | (23.16%) | 3014 | 0.0028 * |
| 60–69 | 1828 | (56.86%) | 1387 | (43.14%) | 3215 | 341 | (53.36%) | 298 | (46.64%) | 639 | 0.1064 |
| ≥70 | 197 | (29.1%) | 480 | (70.9%) | 677 | 40 | (23.53%) | 130 | (76.47%) | 170 | 0.1532 |
Abbreviations: MetS: metabolic syndrome; Non-MetS, without metabolic syndrome. * p values between Non-MetS and MetS were tested using the Fisher’s exact test a. * Statistically significant. p < 0.05.